KURA – Kura Oncology, Inc.
KURA — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
15.97
Margin Of Safety %
Put/Call OI Ratio
0.79
EPS Next Q Diff
-0.06
EPS Last/This Y
-0.26
EPS This/Next Y
0.86
Price
9.58
Target Price
31.17
Analyst Recom
1.2
Performance Q
Upside
-555.1%
Beta
0.39
Ticker: KURA
20 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | KURA | 10.9 | 0.21 | 0.60 | 10063 |
| 2026-07-14 | KURA | 11.23 | 0.22 | 0.72 | 10166 |
| 2026-07-15 | KURA | 11.34 | 0.23 | 1.54 | 10258 |
| 2026-07-16 | KURA | 10.89 | 0.22 | 1.01 | 10213 |
| 2026-07-17 | KURA | 10.85 | 0.24 | 1.50 | 9972 |
| 2026-07-20 | KURA | 10.67 | 0.58 | 1.15 | 3533 |
| 2026-07-21 | KURA | 10.88 | 0.57 | 0.63 | 4219 |
| 2026-07-22 | KURA | 10.53 | 0.52 | 0.13 | 4852 |
| 2026-07-23 | KURA | 10.44 | 0.45 | 78.33 | 5487 |
| 2026-07-24 | KURA | 10.39 | 0.48 | 21.64 | 5613 |
| 2026-07-27 | KURA | 10.15 | 0.49 | 0.00 | 5651 |
| 2026-07-28 | KURA | 9.3 | 0.47 | 4.99 | 5647 |
| 2026-07-29 | KURA | 8.93 | 0.63 | 0.33 | 6485 |
| 2026-07-30 | KURA | 9.31 | 0.62 | 5.27 | 6614 |
| 2026-07-31 | KURA | 9.02 | 0.64 | 13.61 | 6683 |
| 2026-08-03 | KURA | 9.18 | 0.78 | 1.78 | 7418 |
| 2026-08-04 | KURA | 9.47 | 0.78 | 1.24 | 7492 |
| 2026-08-05 | KURA | 9.2 | 0.76 | 2.60 | 7914 |
| 2026-08-06 | KURA | 9.28 | 0.79 | 1.28 | 8162 |
| 2026-08-07 | KURA | 9.57 | 0.79 | 1.22 | 8271 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | KURA | 10.91 | -18.1 | -13.5 | -3.46 |
| 2026-07-14 | KURA | 11.23 | -18.1 | -72.7 | -3.46 |
| 2026-07-15 | KURA | 11.34 | -18.1 | -54.4 | -3.46 |
| 2026-07-16 | KURA | 10.89 | -18.1 | -18.2 | -3.46 |
| 2026-07-17 | KURA | 10.86 | -18.1 | -47.0 | -3.46 |
| 2026-07-20 | KURA | 10.68 | -18.1 | -34.7 | -3.46 |
| 2026-07-21 | KURA | 10.89 | -18.1 | -65.0 | -3.46 |
| 2026-07-22 | KURA | 10.53 | -18.1 | -21.4 | -3.46 |
| 2026-07-23 | KURA | 10.44 | -18.1 | -40.7 | -3.46 |
| 2026-07-24 | KURA | 10.40 | -16.7 | -43.5 | -3.44 |
| 2026-07-27 | KURA | 10.13 | -16.7 | -26.7 | -3.44 |
| 2026-07-28 | KURA | 9.30 | -16.7 | 27.3 | -3.44 |
| 2026-07-29 | KURA | 8.92 | -16.7 | -5.3 | -3.44 |
| 2026-07-30 | KURA | 9.32 | -16.7 | -99.0 | -3.44 |
| 2026-07-31 | KURA | 9.01 | -16.7 | -14.5 | -3.44 |
| 2026-08-03 | KURA | 9.19 | -16.7 | -68.3 | -3.44 |
| 2026-08-04 | KURA | 9.19 | -16.7 | -68.3 | -3.44 |
| 2026-08-05 | KURA | 9.20 | -16.7 | -20.2 | -3.44 |
| 2026-08-06 | KURA | 9.29 | -16.7 | -58.3 | -3.44 |
| 2026-08-07 | KURA | 9.58 | -16.7 | -80.6 | -3.44 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | KURA | -4.66 | -0.60 | 17.55 |
| 2026-07-14 | KURA | -4.66 | -0.60 | 17.55 |
| 2026-07-15 | KURA | -4.66 | -0.60 | 17.55 |
| 2026-07-16 | KURA | -4.66 | -0.60 | 17.55 |
| 2026-07-17 | KURA | -4.66 | -0.60 | 17.55 |
| 2026-07-20 | KURA | -4.66 | -0.36 | 17.55 |
| 2026-07-21 | KURA | -4.66 | -0.36 | 17.55 |
| 2026-07-22 | KURA | -4.66 | -0.36 | 17.55 |
| 2026-07-23 | KURA | -4.66 | -0.36 | 17.55 |
| 2026-07-24 | KURA | -4.66 | -0.36 | 17.55 |
| 2026-07-27 | KURA | -4.66 | -0.32 | 15.97 |
| 2026-07-28 | KURA | -3.47 | -0.32 | 15.97 |
| 2026-07-29 | KURA | -3.47 | -0.32 | 15.97 |
| 2026-07-30 | KURA | -3.47 | -0.32 | 15.97 |
| 2026-07-31 | KURA | -3.47 | -0.32 | 15.97 |
| 2026-08-03 | KURA | -3.47 | -0.03 | 15.97 |
| 2026-08-04 | KURA | -3.47 | -0.03 | 15.97 |
| 2026-08-06 | KURA | -3.47 | -0.03 | 15.97 |
| 2026-08-07 | KURA | -3.47 | -0.03 | 15.97 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
19 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.83
Avg. EPS Est. Current Quarter
-0.88
Avg. EPS Est. Next Quarter
-0.89
Insider Transactions
-3.47
Institutional Transactions
-0.03
Beta
0.39
Average Sales Estimate Current Quarter
20
Average Sales Estimate Next Quarter
23
Fair Value
Quality Score
37
Growth Score
24
Sentiment Score
37
Actual DrawDown %
60.4
Max Drawdown 5-Year %
-76.5
Target Price
31.17
P/E
Forward P/E
PEG
P/S
11.86
P/B
7.87
P/Free Cash Flow
EPS
-3.35
Average EPS Est. Cur. Y
-3.44
EPS Next Y. (Est.)
-2.58
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-411.19
Relative Volume
0.43
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
-80.6
◆
KURA
Healthcare
$9.57
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
0/20
Pullback
17/25
Volume
11/15
Valuation
10/20
TP/AR
2/10
Options
3/10
RSI
44.5
Range 1M
21.8%
Sup Dist
4.9%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
1/25
Growth
5/30
Estimates
0/20
Inst/Vol
0/15
Options
5/10
EPS Yr
-9.7%
52W%
58.4%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+225.7% upside
Quality
6/30
Valuation
16/30
Growth
2/25
Stability
7/10
LT Trend
0/5
Upside
+225.7%
Quality
37
Click a card to see score breakdown
Full Analysis →
KURA — P/E HistoricalBiotechnology
Sector: Healthcare
Industry: Biotechnology
Employees: 260
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
KURA
Latest News
—
Caricamento notizie per KURA…
stock quote shares KURA – Kura Oncology, Inc. Stock Price stock today
news today KURA – Kura Oncology, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KURA – Kura Oncology, Inc. yahoo finance google finance
stock history KURA – Kura Oncology, Inc. invest stock market
stock prices KURA premarket after hours
ticker KURA fair value insiders trading